Pembrolizumab in patients with rare and ultra-rare sarcomas (AcSé Pembrolizumab): analysis of a subgroup from a non-randomised, open-label, phase 2, basket trial
Titel:
Pembrolizumab in patients with rare and ultra-rare sarcomas (AcSé Pembrolizumab): analysis of a subgroup from a non-randomised, open-label, phase 2, basket trial
Auteur:
Blay, Jean-Yves Chevret, Sylvie Le Cesne, Axel Brahmi, Mehdi Penel, Nicolas Cousin, Sophie Bertucci, Francois Bompas, Emmanuelle Ryckewaert, Thomas Soibinet, Pauline Boudou-Rouquette, Pascaline Saada Bouzid, Esma Soulie, Patrick Valentin, Thibaud Lotz, Jean-Pierre Tosi, Diego Neviere, Zoé Cancel, Mathilde Ray-Coquard, Isabelle Gambotti, Laetitia Legrand, Frédéric Lamrani-Ghaouti, Assia Simon, Clotilde Even, Caroline Massard, Christophe